Compare
Trulieve Cannabis Corp. vs Curaleaf Holdings, Inc. vs USANA Health Sciences Inc vs Tilray Brands, Inc.
| Latest fiscal year | Trulieve Cannabis Corp. TRLV | Curaleaf Holdings, Inc. CURLF | USANA Health Sciences Inc USNA | Tilray Brands, Inc. TLRY |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-01-03 | 2026-05-31 |
| Revenue | $1.18B | $1.27B | $925.26M | $915.45M |
| Revenue growth (YoY) | -0.4% | -5.0% | +8.3% | +11.5% |
| Gross margin | 60.2% | 49.8% | 78.3% | 28.4% |
| Operating margin | 12.1% | 2.0% | 4.0% | -6.9% |
| Net margin | -10.3% | -18.2% | 1.2% | -13.3% |
| Net income | -$122.25M | -$231.07M | $10.76M | -$121.40M |
| EPS (Diluted) | -$0.58 | -$0.35 | $0.58 | -$1.09 |
| Operating cash flow | $272.82M | $137.71M | $22.35M | -$69.14M |
| Free cash flow | $228.63M | $74.27M | $8.53M | n/a |
| Cash & equivalents | $255.53M | n/a | $158.38M | $225.98M |
| Total assets | $2.70B | $2.85B | $742.91M | $2.33B |
| Total liabilities | $1.55B | $2.01B | $156.64M | $733.14M |
| Shareholders' equity | $1.14B | $756.35M | $533.10M | $1.61B |
| Return on year-end equity | -10.7% | -30.6% | 2.0% | -7.5% |
| Shares outstanding | 192.31M | n/a | 18.28M | 131.68M |
Revenue, most recent five fiscal years
| Fiscal year | Trulieve Cannabis Corp. | Curaleaf Holdings, Inc. | USANA Health Sciences Inc | Tilray Brands, Inc. |
|---|---|---|---|---|
| Latest | $1.18B Ended 2025-12-31 | $1.27B Ended 2025-12-31 | $925.26M Ended 2026-01-03 | $915.45M Ended 2026-05-31 |
| 1 year earlier | $1.19B Ended 2024-12-31 | $1.33B Ended 2024-12-31 | $854.50M Ended 2024-12-28 | $821.31M Ended 2025-05-31 |
| 2 years earlier | $1.13B Ended 2023-12-31 | $1.35B Ended 2023-12-31 | $921.01M Ended 2023-12-30 | $788.94M Ended 2024-05-31 |
| 3 years earlier | $1.22B Ended 2022-12-31 | $1.28B Ended 2022-12-31 | $998.60M Ended 2022-12-31 | $627.12M Ended 2023-05-31 |
| 4 years earlier | $931.93M Ended 2021-12-31 | $1.20B Ended 2021-12-31 | $1.19B Ended 2022-01-01 | $628.37M Ended 2022-05-31 |